Batycky Alka 4
4 · Landos Biopharma, Inc. · Filed Jun 1, 2023
Insider Transaction Report
Form 4
Batycky Alka
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-30+3,600→ 3,600 totalExercise: $3.05Exp: 2033-05-29→ Common Stock (3,600 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the option will vest and become exercisable in 36 equal monthly installments beginning on May 30, 2023, subject to the Reporting Person's continuous service with the Issuer on each such date.